Valrubicin intravesical solution Other Information |
valrubicin; Valstar |
Valrubicin Systematic (IUPAC) name [2-oxo-2-[2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetyl) amino-tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-1,2,3,4-tetrahydrotetracen- 2-yl]-ethyl]pentanoate Identifiers CAS number 56124-62-0 ATC code L01DB09 PubChem 41744 DrugBank APRD00662 Chemical data Formula C34H36F3NO13 Mol. weight 723.644 g/mol Pharmacokinetic data Bioavailability ? Protein binding >99% Metabolism ? Half life ...
Wikipedia - [full article]
From the WEST scientific·clinical |
From the EAST traditional·alternative |
|
|
|
|
Valstar Consumer Information
... Valstar is used for treatment of patients with BCG-resistant cancer of the urinary bladder for whom surgical removal of the bladder is not safe. Treatment with Valstar is through drug instillation int...
Source: U.S. Food and Drug Administration
|
|

Not Signed In -


